Trial Profile
The Combination Tenofovir/Lamivudine (Emtricitabine) /Efavirenz (Nevirapine) Better Tolerated Than Zidovudine/Lamivudine/Nevirapine in a Prospective Observational Study of Adverse Effects in Newly Treated Individuals in Burkina Faso
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 09 Oct 2015
Price :
$35
*
At a glance
- Drugs Efavirenz (Primary) ; Emtricitabine (Primary) ; Lamivudine (Primary) ; Nevirapine (Primary) ; Tenofovir disoproxil fumarate (Primary) ; Abacavir; Lopinavir; Zidovudine
- Indications HIV infections
- Focus Adverse reactions
- 09 Oct 2015 New trial record
- 26 Aug 2015 Results presented at the 31st International Conference on Pharmacoepidemiology and Therapeutic Risk Management.